Friday, May 29, 2015

Positive Clinical Data From ChemoCentryx Phase II Trial in Diabetic Nephropathy to be Presented at the 52nd Annual ERA-EDTA Congress

Positive Clinical Data From ChemoCentryx Phase II Trial in Diabetic Nephropathy to be Presented at the 52nd Annual ERA-EDTA Congress

No comments:

Post a Comment